Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-12

Clinical Trial Update: Adjunctive Benefit of a Xenogenic Collagen Matrix [NA]

View source ↗

Summary

A completed clinical trial evaluating a xenogenic collagen matrix as an adjunctive therapy for gingival recession reports an adjunctive benefit.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Xenogenic collagen matrix (Xenogenic collagen matrix)

Snippet

Sponsor: Roberto Rotundo | Conditions: Gingival Recession | NA | Status: COMPLETED